No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CHE240621C570000
- 2.13
- 0.000.00%
15min DelayTrading Jun 13 15:45 ET
0.00High0.00Low
0.00Open2.13Pre Close0 Volume1 Open Interest570.00Strike Price0.00Turnover62.79%IV7.44%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry2.13Extrinsic Value100Contract SizeAmericanOptions Type0.1341Delta0.0067Gamma250.00Leverage Ratio-0.9911Theta0.0065Rho33.53Eff Leverage0.1113Vega
Intraday
- 5D
- Daily
News
Insider Selling: Director Patrick Grace Sells Shares of Chemed Corp (CHE)
Chemed(CHE.US) Director Sells US$153.64K in Common Stock
$Chemed(CHE.US)$ Director GRACE PATRICK P sold 284 shares of common stock on Jun 12, 2024 at an average price of $540.98 for a total value of $153.64K.Source: Announcement What is statement of changes
(CHE) - Analyzing Chemed's Short Interest
Chemed's (NYSE:CHE) short percent of float has risen 15.52% since its last report. The company recently reported that it has 350 thousand shares sold short, which is 2.68% of all regular shares that a
Form 144 | Chemed(CHE.US) Director Proposes to Sell 154.28K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Chemed(CHE.US)$ Director Patrick P. Grace intends to sell 284 shares of its common stock on Jun 12, with a total market value of approximately $154.28K. Source: An
Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)
Chemed(CHE.US) Officer Sells US$816.25K in Common Stock
$Chemed(CHE.US)$ Officer MCNAMARA KEVIN J sold 1,500 shares of common stock on Jun 6, 2024 at an average price of $544.17 for a total value of $816.25K.Source: Announcement What is statement of change
Comments
Insiders' substantial selling of Chemed shares over the past year, especially in the last quarter, could be a red flag for investors. The absence of insider purchases during the same period heightens this concern. Despite high insider ownership, the history of share sales adds uncertainty.
Chemed Insiders Sold US$23m Of Shares Suggesting HesitancyChemed's consistent ability to generate high returns on increased capital employed makes it a potential multi-bagger. Despite the stock being more 'expensive' than before, its strong fundamentals make it worthy of further research.
Despite Chemed's poor recent earnings, the high P/E ratio shows investors foresee future growth. They think chances of an earnings slump is low, supporting share price. This suggests strong future growth potential might be making investors pay a premium for the stock.
The market seems to have a higher opinion of Chemed as compared to five years ago, reflecting increased investor sentiment. Recent shareholder returns suggest positive sentiment around the company, possibly hinting at business momentum.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Align Technology(ALGN.US$ - up 11.5%
2. $Textron(TXT.US$ - up 5.2%
3. $STMicroelectronics(STM.US$ - up 4.1%
4. $Lam Research(LRCX.US$ - up 3.9%
5. $RELX PLC(RELX.US$ - up 3.1%
6. $Royal Caribbean(RCL.US$ - up 3.1%
7. $Micron Technology(MU.US$ - up 3.1%
8. $Western Digital(WDC.US$ - up 2.9...
Gap Ups
1. $Align Technology(ALGN.US$ - up 11.5%
2. $Textron(TXT.US$ - up 5.2%
3. $STMicroelectronics(STM.US$ - up 4.1%
4. $Lam Research(LRCX.US$ - up 3.9%
5. $RELX PLC(RELX.US$ - up 3.1%
6. $Royal Caribbean(RCL.US$ - up 3.1%
7. $Micron Technology(MU.US$ - up 3.1%
8. $Western Digital(WDC.US$ - up 2.9...
+17
18
Read more